James Alecxih - Net Worth and Insider Trading

James Alecxih Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Alecxih owns 4 companies in total, including ViewRay Inc (VRAYQ) , Nevro Corp (NVRO) , and TriSalus Life Sciences Inc (TLSI) among others .

Click here to see the complete history of James Alecxih’s form 4 insider trades.

Insider Ownership Summary of James Alecxih

Ticker	Comapny	Transaction Date	Type of Owner
VRAYQ	ViewRay Inc	2018-09-17	Chief Commercial Officer
NVRO	Nevro Corp	2017-12-12	Vice President & Sales
TLSI	TriSalus Life Sciences Inc	2023-08-10	President & Device Technology
MTAC	MedTech Acquisition Corp	2023-08-10	President & Device Technology

James Alecxih Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James Alecxih Ownership Network

Ownership Network List of James Alecxih

No Data

Ownership Network Relation of James Alecxih

James Alecxih Owned Company Details

What does ViewRay Inc do?

Who are the key executives at ViewRay Inc?

James Alecxih is the Chief Commercial Officer of ViewRay Inc. Other key executives at ViewRay Inc include SVP & General Counsel Sanket Shah , 10 percent owner Farhad Fred Ebrahimi , and Chief Commercial Officer Paul Jr Ziegler .

ViewRay Inc (VRAYQ) Insider Trades Summary

Over the past 18 months, James Alecxih made no insider transaction in ViewRay Inc (VRAYQ). Other recent insider transactions involving ViewRay Inc (VRAYQ) include a net sale of 110,324 shares made by B Kristine Johnson , a net sale of 8,203,610 shares made by Farhad Fred Ebrahimi , and a net sale of 2,408,747 shares made by Scott William Drake .

In summary, during the past 3 months, insiders sold 0 shares of ViewRay Inc (VRAYQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,529,227 shares of ViewRay Inc (VRAYQ) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 13,504,227 shares.

ViewRay Inc (VRAYQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

ViewRay Inc Insider Transactions

No Available Data

What does Nevro Corp do?

Who are the key executives at Nevro Corp?

James Alecxih is the Vice President & Sales of Nevro Corp. Other key executives at Nevro Corp include Chief Commercial Officer Greg Siller , President & CEO Kevin R Thornal , and Chief Accounting Officer Richard B. Carter .

Nevro Corp (NVRO) Insider Trades Summary

Over the past 18 months, James Alecxih made no insider transaction in Nevro Corp (NVRO). Other recent insider transactions involving Nevro Corp (NVRO) include a net purchase of 7,500 shares made by Shawn Mccormick ,

In summary, during the past 3 months, insiders sold 0 shares of Nevro Corp (NVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nevro Corp (NVRO) were sold and 7,500 shares were bought by its insiders, resulting in a net purchase of 7,500 shares.

Nevro Corp (NVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nevro Corp Insider Transactions

No Available Data

What does TriSalus Life Sciences Inc do?

Who are the key executives at TriSalus Life Sciences Inc?

James Alecxih is the President & Device Technology of TriSalus Life Sciences Inc. Other key executives at TriSalus Life Sciences Inc include President & Therapeutics Jodi Devlin , 10 percent owner Equity Ab Frankenius , and director & 10 percent owner Mats Wahlstrom .

TriSalus Life Sciences Inc (TLSI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TriSalus Life Sciences Inc (TLSI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriSalus Life Sciences Inc (TLSI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriSalus Life Sciences Inc (TLSI)'s detailed insider trading history can be found in Insider Trading Tracker table.

TriSalus Life Sciences Inc Insider Transactions

No Available Data

What does MedTech Acquisition Corp do?

Who are the key executives at MedTech Acquisition Corp?

James Alecxih is the President & Device Technology of MedTech Acquisition Corp. Other key executives at MedTech Acquisition Corp include President & Therapeutics Jodi Devlin , 10 percent owner Equity Ab Frankenius , and director & 10 percent owner Mats Wahlstrom .

MedTech Acquisition Corp (MTAC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MedTech Acquisition Corp (MTAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MedTech Acquisition Corp (MTAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MedTech Acquisition Corp (MTAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

MedTech Acquisition Corp Insider Transactions

No Available Data

James Alecxih Mailing Address

Above is the net worth, insider trading, and ownership report for James Alecxih. You might contact James Alecxih via mailing address: C/o Nevro Corp., 1800 Bridge Parkway, Redwood City Ca 94065.

Discussions on James Alecxih

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.